(Q73396676)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12747951%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Inhibition of tumor rejection by gammadelta T cells and IL-10 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12747951%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Inhibition of tumor rejection by γδ T cells and IL-10 (English)

1 reference

https://api.crossref.org/works/10.1016/S0008-8749(03)00066-2

2 January 2024

1 reference

https://api.crossref.org/works/10.1016/S0008-8749(03)00066-2

2 January 2024

author name string

Yong Ke

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12747951%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Linda M. Kapp

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12747951

2 January 2024

Judith A. Kapp

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12747951

2 January 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12747951

2 January 2024

publication date

1 February 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12747951%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

3 November 2019

https://api.elsevier.com/content/article/PII:S0008874903000662?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0008-8749(03)00066-2

https://api.elsevier.com/content/article/PII:S0008874903000662?httpAccept=text/plain

2 January 2024

1 reference

https://api.crossref.org/works/10.1016/S0008-8749(03)00066-2

2 January 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12747951%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

221

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12747951%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12747951%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

107-114

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12747951%20AND%20SRC:MED&resulttype=core&format=json

Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900066-2

Tumor immunology: present perspectives.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900066-2

A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900066-2

Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900066-2

Co-stimulation in T cell responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900066-2

Tumor immunotherapy by vaccination with cytokine gene transfected cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900066-2

Gene-modified tumor cells as cellular vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900066-2

Tolerance and cancer: a critical issue in tumor immunology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900066-2

Induction of antigen-specific T cell anergy: An early event in the course of tumor progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900066-2

Peripheral T cell tolerance as a tumor escape mechanism: deletion of CD4+ T cells specific for a monoclonal immunoglobulin idiotype secreted by a plasmacytoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900066-2

Studies in antibody response of mice to tumour inoculation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900066-2

Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900066-2

Introduction of soluble protein into the class I pathway of antigen processing and presentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900066-2

T cell receptor δ gene mutant mice: Independent generation of αβ T cells and programmed rearrangements of γδ TCR genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900066-2

RAG-1-deficient mice have no mature B and T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900066-2

Interleukin-10-deficient mice develop chronic enterocolitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900066-2

CD8 is needed for development of cytotoxic T cells but not helper T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900066-2

Functional modifications of cytotoxic T-lymphocyte T200 glycoprotein recognized by monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900066-2

Ovalbumin injected with complete Freund's adjuvant stimulates cytolytic responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900066-2

Intraepithelial lymphocytes. Anatomical site, not T cell receptor form, dictates phenotype and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900066-2

Antigenic epitopes regulate the phenotype of CD8+ CTL primed by exogenous antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900066-2

Regulation of IgE responses to inhaled antigen in mice by antigen-specific gamma delta T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900066-2

Orally induced, peptide-specific gamma/delta TCR+ cells suppress experimental autoimmune uveitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900066-2

T cell receptor-triggered activation of intraepithelial lymphocytes in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900066-2

Differential production of interferon-γ and interleukin-4 in response to Th1- and Th2-stimulating pathogens by γδ T cells in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900066-2

Profiles of cytokine mRNA expressed by dendritic epidermal T cells in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900066-2

A novel subset of adult gamma delta thymocytes that secretes a distinct pattern of cytokines and expresses a very restricted T cell receptor repertoire

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900066-2

Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900066-2

Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900066-2

Human gammadelta T cells: a nonredundant system in the immune-surveillance against cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900066-2

Role of gammadelta T cells in tumor immunity and their control by NK receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900066-2

Tumor formation suppressed in gammadeltaT knock-out mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900066-2

Suppression of cytotoxic T lymphocyte activity by gamma/delta T cells in tumor-bearing mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900066-2

Expansion of the gammadelta T cell subset in vivo during bloodstage malaria in B cell-deficient mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900066-2

Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900066-2

Innate and adaptive immunity to tumors: IL-12 is required for optimal responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900066-2

Human tumor antigens are ready to fly.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900066-2

inferred from DOI database lookup

7 January 2021

based on heuristic

17

52

6287

Zhou

1992

1 reference

https://api.crossref.org/works/10.1016/S0008-8749(03)00066-2

2 January 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12747951%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference